Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
small molecules
Biotech
Voyager sets sail on neuro research trek with Transition Bio
Transition Bio will aim to identify small molecule candidates for ALS and dementia, which Voyager will then have the option to license.
Darren Incorvaia
Nov 10, 2025 5:23pm
BridgeBio aces phase 3 rare disease test, clearing path to FDA
Oct 27, 2025 7:00am
Praxis plots path to FDA after phase 3 wins in essential tremor
Oct 16, 2025 11:48am
Lilly pads oral GLP-1 case with pair of phase 3 diabetes wins
Oct 15, 2025 9:48am
Merck inks $349M biobucks deal to apply AI to tricky targets
Sep 23, 2025 7:00am
Lilly links up with Gate in $856M biobucks deal
Jul 24, 2025 2:32pm